Electric field responsive nanotransducers for glioblastoma

BACKGROUND: Electric field therapies such as Tumor Treating Fields (TTFields) have emerged as a bioelectronic treatment for isocitrate dehydrogenase wild-type and IDH mutant grade 4 astrocytoma Glioblastoma (GBM). TTFields rely on alternating current (AC) electric fields (EF) leading to the disrupti...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Akhil, Jobson, Isobel, Griffin, Michaela, Rahman, Ruman, Smith, Stuart, Rawson, Frankie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580136/
https://www.ncbi.nlm.nih.gov/pubmed/36258238
http://dx.doi.org/10.1186/s42234-022-00099-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580136/
https://www.ncbi.nlm.nih.gov/pubmed/36258238
http://dx.doi.org/10.1186/s42234-022-00099-7

Ejemplares similares